Search | Virtual Health Library

1.

Early complete response as a validated surrogate marker in extranodal marginal zone lymphoma systemic therapy.

Bommier, Côme; Zucca, Emanuele; Chevret, Sylvie; Conconi, Annarita; Nowakowski, Grzegorz; Maurer, Matthew J; Cerhan, James R; Thieblemont, Catherine; Lambert, Jérôme.

Blood ; 143(5): 422-428, 2024 Feb 01.

Article in English | MEDLINE | ID: mdl-37801707

2.

The ATR inhibitor elimusertib exhibits anti-lymphoma activity and synergizes with the PI3K inhibitor copanlisib.

Sartori, Giulio; Tarantelli, Chiara; Spriano, Filippo; Gaudio, Eugenio; Cascione, Luciano; Mascia, Michele; Barreca, Marilia; Arribas, Alberto J; Licenziato, Luca; Golino, Gaetanina; Ferragamo, Adele; Pileri, Stefano; Damia, Giovanna; Zucca, Emanuele; Stathis, Anastasios; Politz, Oliver; Wengner, Antje M; Bertoni, Francesco.

Br J Haematol ; 204(1): 191-205, 2024 01.

Article in English | MEDLINE | ID: mdl-38011941

3.

The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee.

Campo, Elias; Jaffe, Elaine S; Cook, James R; Quintanilla-Martinez, Leticia; Swerdlow, Steven H; Anderson, Kenneth C; Brousset, Pierre; Cerroni, Lorenzo; de Leval, Laurence; Dirnhofer, Stefan; Dogan, Ahmet; Feldman, Andrew L; Fend, Falko; Friedberg, Jonathan W; Gaulard, Philippe; Ghia, Paolo; Horwitz, Steven M; King, Rebecca L; Salles, Gilles; San-Miguel, Jesus; Seymour, John F; Treon, Steven P; Vose, Julie M; Zucca, Emanuele; Advani, Ranjana; Ansell, Stephen; Au, Wing-Yan; Barrionuevo, Carlos; Bergsagel, Leif; Chan, Wing C; Cohen, Jeffrey I; d'Amore, Francesco; Davies, Andrew; Falini, Brunangelo; Ghobrial, Irene M; Goodlad, John R; Gribben, John G; Hsi, Eric D; Kahl, Brad S; Kim, Won-Seog; Kumar, Shaji; LaCasce, Ann S; Laurent, Camille; Lenz, Georg; Leonard, John P; Link, Michael P; Lopez-Guillermo, Armando; Mateos, Maria Victoria; Macintyre, Elizabeth; Melnick, Ari M.

Blood ; 140(11): 1229-1253, 2022 09 15.

Article in English | MEDLINE | ID: mdl-35653592

4.

Targeting CD19-positive lymphomas with the antibody-drug conjugate loncastuximab tesirine: preclinical evidence as single agent and in combination therapy.

Tarantelli, Chiara; Wald, David; Munz, Nicolas; Spriano, Filippo; Bruscaggin, Alessio; Cannas, Eleonora; Cascione, Luciano; Gaudio, Eugenio; Arribas, Alberto J; Manjappa, Shivaprasad; Golino, Gaetanina; Scalise, Lorenzo; Cacciapuoti, Maria Teresa; Zucca, Emanuele; Stathis, Anastasios; Inghirami, Giorgio; Van Berkel, Patrick H; Rossi, Davide; Caimi, Paolo F; Zammarchi, Francesca; Bertoni, Francesco.

Haematologica ; 2024 May 09.

Article in English | MEDLINE | ID: mdl-38721745

5.

Bendamustine and rituximab as first-line treatment for symptomatic splenic marginal zone lymphoma: long-term outcome and impact of early unmeasurable minimal residual disease attainment from the BRISMA/IELSG36 phase II study.

Iannitto, Emilio; Ferrero, Simone; Bommier, Côme; Drandi, Daniela; Ferrante, Martina; Bouabdallah, Krimo; Carras, Sylvain; Gini, Guido; Camus, Vincent; Mancuso, Salvatrice; Marcheselli, Luigi; Ferrari, Angela; Merli, Michele; Tessoulin, Benoit; Stelitano, Caterina; Beldjord, Kheira; Roti, Giovanni; Jardin, Fabrice; Castagnari, Barbara; Palombi, Francesca; Baseggio, Lucile; Traverse-Glehen, Alexandra; Tripodo, Claudio; Liberati, Anna Marina; Parolini, Margherita; Usai, Sara; Patti, Caterina; Federico, Massimo; Musso, Maurizio; Ladetto, Marco; Zucca, Emanuele; Thieblemont, Catherine.

Haematologica ; 2024 Mar 14.

Article in English | MEDLINE | ID: mdl-38497158

6.

IELSG38: phase II trial of front-line chlorambucil plus subcutaneous rituximab induction and maintenance in mucosa-associated lymphoid tissue lymphoma.

Stathis, Anastasios; Pirosa, Maria Cristina; Orsucci, Lorella; Feugier, Pierre; Tani, Monica; Ghesquières, Hervé; Musuraca, Gerardo; Rossi, Francesca Gaia; Merli, Francesco; Guièze, Romain; Gyan, Emmanuel; Gini, Guido; Marino, Dario; Gressin, Remy; Morschhauser, Franck; Cavallo, Federica; Palombi, Francesca; Conconi, Annarita; Tessoulin, Benoît; Tilly, Hervé; Zanni, Manuela; Cabras, Maria Giuseppina; Capochiani, Enrico; Califano, Catello; Celli, Melania; Pulsoni, Alessandro; Angrilli, Francesco; Occhini, Ubaldo; Casasnovas, René-Olivier; Cartron, Guillaume; Devizzi, Liliana; Haioun, Corinne; Liberati, Anna Marina; Houot, Roch; Merli, Michele; Pietrantuono, Giuseppe; Re, Francesca; Spina, Michele; Landi, Francesco; Cavalli, Franco; Bertoni, Francesco; Rossi, Davide; Ielmini, Nicoletta; Borgo, Elena; Luminari, Stefano; Zucca, Emanuele; Thieblemont, Catherine.

Haematologica ; 2024 Feb 22.

Article in English | MEDLINE | ID: mdl-38385243

7.

ETS1 phosphorylation at threonine 38 is associated with the cell of origin of diffuse large B cell lymphoma and sustains the growth of tumour cells.

Chung, Elaine Y L; Sartori, Giulio; Ponzoni, Maurilio; Cascione, Luciano; Priebe, Valdemar; Xu-Monette, Zijun Y; Fang, Xiaosheng; Zhang, Mingzhi; Visco, Carlo; Tzankov, Alexandar; Rinaldi, Andrea; Sgrignani, Jacopo; Zucca, Emanuele; Rossi, Davide; Cavalli, Andrea; Inghirami, Giorgio; Scott, David W; Young, Ken H; Bertoni, Francesco.

Br J Haematol ; 203(2): 244-254, 2023 Oct.

Article in English | MEDLINE | ID: mdl-37584198

8.

Marginal zone lymphomas.

Zucca, Emanuele; Rossi, Davide; Bertoni, Francesco.

Hematol Oncol ; 41 Suppl 1: 88-91, 2023 Jun.

Article in English | MEDLINE | ID: mdl-37294969

9.

CT-based body composition in diffuse large B cell lymphoma patients: changes after treatment and association with survival.

Pirosa, Maria Cristina; Esposito, Fabiana; Raia, Giorgio; Chianca, Vito; Cozzi, Andrea; Ruinelli, Lorenzo; Ceriani, Luca; Zucca, Emanuele; Del Grande, Filippo; Rizzo, Stefania.

Radiol Med ; 128(12): 1497-1507, 2023 Dec.

Article in English | MEDLINE | ID: mdl-37752299

10.

Bacterial infection-driven lymphomagenesis.

Vannata, Barbara; Pirosa, Maria Cristina; Bertoni, Francesco; Rossi, Davide; Zucca, Emanuele.

Curr Opin Oncol ; 34(5): 454-463, 2022 09 01.

Article in English | MEDLINE | ID: mdl-35880463

11.

International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia.

Condoluci, Adalgisa; Terzi di Bergamo, Lodovico; Langerbeins, Petra; Hoechstetter, Manuela A; Herling, Carmen D; De Paoli, Lorenzo; Delgado, Julio; Rabe, Kari G; Gentile, Massimo; Doubek, Michael; Mauro, Francesca R; Chiodin, Giorgia; Mattsson, Mattias; Bahlo, Jasmin; Cutrona, Giovanna; Kotaskova, Jana; Deambrogi, Clara; Smedby, Karin E; Spina, Valeria; Bruscaggin, Alessio; Wu, Wei; Moia, Riccardo; Bianchi, Elena; Gerber, Bernhard; Zucca, Emanuele; Gillessen, Silke; Ghielmini, Michele; Cavalli, Franco; Stussi, Georg; Hess, Mark A; Baumann, Tycho S; Neri, Antonino; Ferrarini, Manlio; Rosenquist, Richard; Forconi, Francesco; Foà, Robin; Pospisilova, Sarka; Morabito, Fortunato; Stilgenbauer, Stephan; Döhner, Hartmut; Parikh, Sameer A; Wierda, William G; Montserrat, Emili; Gaidano, Gianluca; Hallek, Michael; Rossi, Davide.

Blood ; 135(21): 1859-1869, 2020 05 21.

Article in English | MEDLINE | ID: mdl-32267500

12.

Resistance to PI3KÎ´ inhibitors in marginal zone lymphoma can be reverted by targeting the IL-6/PDGFRA axis.

Arribas, Alberto J; Napoli, Sara; Cascione, Luciano; Sartori, Giulio; Barnabei, Laura; Gaudio, Eugenio; Tarantelli, Chiara; Mensah, Afua Adjeiwaa; Spriano, Filippo; Zucchetto, Antonella; Rossi, Francesca M; Rinaldi, Andrea; Castro de Moura, Manuel; Jovic, Sandra; Bordone-Pittau, Roberta; Di Veroli, Alessandra; Stathis, Anastasios; Cruciani, Gabriele; Stussi, Georg; Gattei, Valter; Brown, Jennifer R; Esteller, Manel; Zucca, Emanuele; Rossi, Davide; Bertoni, Francesco.

Haematologica ; 107(11): 2685-2697, 2022 11 01.

Article in English | MEDLINE | ID: mdl-35484662

13.

Finding a consensus on time-to-event endpoints definitions in marginal zone lymphoma: A Delphi method.

Bommier, Côme; Lambert, Jérôme; Nowakowski, Grzegorz; Zucca, Emanuele; Thieblemont, Catherine.

Hematol Oncol ; 40(5): 1086-1089, 2022 Dec.

Article in English | MEDLINE | ID: mdl-35299287

14.

Generation and validation of a PET radiomics model that predicts survival in diffuse large B cell lymphoma treated with R-CHOP14: A SAKK 38/07 trial post-hoc analysis.

Ceriani, Luca; Milan, Lisa; Cascione, Luciano; Gritti, Giuseppe; Dalmasso, Federico; Esposito, Fabiana; Pirosa, Maria Cristina; Schär, Sämi; Bruno, Andrea; Dirnhofer, Stephan; Giovanella, Luca; Hayoz, Stefanie; Mamot, Christoph; Rambaldi, Alessandro; Chauvie, Stephane; Zucca, Emanuele.

Hematol Oncol ; 40(1): 11-21, 2022 Feb.

Article in English | MEDLINE | ID: mdl-34714558

15.

Revised MALT-IPI: A new predictive model that identifies high-risk patients with extranodal marginal zone lymphoma.

Alderuccio, Juan Pablo; Reis, Isildinha M; Habermann, Thomas M; Link, Brian K; Thieblemont, Catherine; Conconi, Annarita; Larson, Melissa C; Cascione, Luciano; Zhao, Wei; Cerhan, James R; Zucca, Emanuele; Lossos, Izidore S.

Am J Hematol ; 97(12): 1529-1537, 2022 12.

Article in English | MEDLINE | ID: mdl-36057138

16.

Prognostic value of POD24 validation in follicular lymphoma patients initially treated with chemotherapy-free regimens in a pooled analysis of three randomized trials of the Swiss Group for Clinical Cancer Research (SAKK).

Moccia, Alden Alberto; Schär, Sämi; Hayoz, Stefanie; Pirosa, Maria Cristina; Taverna, Christian; Novak, Urban; Kimby, Eva; Ghielmini, Michele; Zucca, Emanuele.

Br J Haematol ; 192(6): 1031-1034, 2021 03.

Article in English | MEDLINE | ID: mdl-32805081

17.

Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy.

Zucca, Emanuele; Rondeau, Stephanie; Vanazzi, Anna; Østenstad, Bjørn; Mey, Ulrich J M; Rauch, Daniel; Wahlin, Björn E; Hitz, Felicitas; Hernberg, Micaela; Johansson, Ann-Sofie; de Nully Brown, Peter; Hagberg, Hans; Ferreri, Andrés J M; Lohri, Andreas; Novak, Urban; Zander, Thilo; Bersvendsen, Hanne; Bargetzi, Mario; Mingrone, Walter; Krasniqi, Fatime; Dirnhofer, Stefan; Hayoz, Stefanie; Hawle, Hanne; Vilei, Simona Berardi; Ghielmini, Michele; Kimby, Eva.

Blood ; 134(4): 353-362, 2019 07 25.

Article in English | MEDLINE | ID: mdl-31101627

18.

A phase II trial of bendamustine in combination with ofatumumab in patients with relapsed or refractory marginal zone B-cell lymphomas.

Vannata, Barbara; Vanazzi, Anna; Negri, Mara; Liptrott, Sarah Jayne; Bartosek, Anna Amalia; Miani, Monica; Di Sanzo, Alessandro; Cavalli, Franco; Zucca, Emanuele; Stathis, Anastasios.

Hematol Oncol ; 39(1): 60-65, 2021 Feb.

Article in English | MEDLINE | ID: mdl-33103778

19.

Prognostic implications of the microenvironment for follicular lymphoma under immunomodulation therapy.

Menter, Thomas; Tzankov, Alexandar; Zucca, Emanuele; Kimby, Eva; Hultdin, Magnus; Sundström, Christer; Beiske, Klaus; Cogliatti, Sergio; Banz, Yara; Cathomas, Gieri; Karjalainen-Lindsberg, Marja-Liisa; Grobholz, Rainer; Mazzucchelli, Luca; Sander, Birgitta; Hawle, Hanne; Hayoz, Stefanie; Dirnhofer, Stefan.

Br J Haematol ; 189(4): 707-717, 2020 05.

Article in English | MEDLINE | ID: mdl-32012230

20.

Marginal-Zone Lymphomas. Reply.

Bertoni, Francesco; Rossi, Davide; Zucca, Emanuele.

N Engl J Med ; 386(20): 1962-1963, 2022 05 19.

Article in English | MEDLINE | ID: mdl-35584172

Virtual Health Library

United States - Mexico Border

Your selection (0)

Export format:

Export: